Punch & Associates Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.98M Sell
23,223
-6
-0% -$2.23K 0.44% 81
2026
Q1
$6.8M Buy
23,229
+3,630
+19% +$1.19M 0.39% 91
2025
Q4
$6.87M Sell
19,599
-3,650
-16% -$1.23M 0.4% 91
2025
Q3
$7.51M Buy
23,249
+86
+0.4% +$26.7K 0.44% 86
2025
Q2
$9.01M Buy
23,163
+930
+4% +$374K 0.55% 75
2025
Q1
$9.67M Sell
22,233
-161
-0.7% -$64.6K 0.63% 68
2024
Q4
$8.26M Sell
22,394
-183
-0.8% -$76.6K 0.45% 93
2024
Q3
$11.7M Sell
22,577
-264
-1% -$141K 0.65% 58
2024
Q2
$12.4M Buy
22,841
+87
+0.4% +$46K 0.72% 47
2024
Q1
$11.8M Sell
22,754
-1,248
-5% -$621K 0.67% 51
2023
Q4
$11.3M Sell
24,002
-378
-2% -$175K 0.66% 52
2023
Q3
$10.6M Sell
24,380
-76
-0.3% -$34.5K 0.68% 53
2023
Q2
$10.9M Sell
24,456
-239
-1% -$110K 0.66% 54
2023
Q1
$11.4M Sell
24,695
-265
-1% -$126K 0.73% 45
2022
Q4
$12.8M Sell
24,960
-247
-1% -$125K 0.83% 33
2022
Q3
$11.4M Buy
25,207
+391
+2% +$187K 0.8% 36
2022
Q2
$12M Sell
24,816
-3,949
-14% -$1.95M 0.84% 28
2022
Q1
$14.1M Buy
28,765
+452
+2% +$207K 0.8% 27
2021
Q4
$13.1M Buy
28,313
+101
+0.4% +$42.5K 0.69% 43
2021
Q3
$10.5M Buy
28,212
+8
+0% +$3.04K 0.6% 56
2021
Q2
$10.8M Sell
28,204
-415
-1% -$159K 0.61% 55
2021
Q1
$10.3M Buy
28,619
+40
+0.1% +$12.9K 0.62% 58
2020
Q4
$9.18M Sell
28,579
-768
-3% -$236K 0.64% 55
2020
Q3
$7.88M Sell
29,347
-382
-1% -$103K 0.68% 51
2020
Q2
$7.82M Sell
29,729
-207
-0.7% -$55.2K 0.71% 41
2020
Q1
$6.8M Buy
29,936
+457
+2% +$125K 0.81% 35
2019
Q4
$8.9M Sell
29,479
-663
-2% -$182K 0.7% 45
2019
Q3
$7.24M Sell
30,142
-295
-1% -$80.8K 0.6% 58
2019
Q2
$8.59M Buy
30,437
+333
+1% +$91K 0.72% 49
2019
Q1
$8.64M Buy
30,104
+692
+2% +$200K 0.74% 45
2018
Q4
$7.72M Sell
29,412
-271
-0.9% -$74.5K 0.74% 37
2018
Q3
$8.13M Buy
29,683
+1,518
+5% +$394K 0.64% 46
2018
Q2
$6.7M Sell
28,165
-427
-1% -$98.9K 0.55% 68
2018
Q1
$6.28M Sell
28,592
-423
-1% -$99.4K 0.55% 68
2017
Q4
$6.53M Sell
29,015
-511
-2% -$109K 0.56% 68
2017
Q3
$5.61M Sell
29,526
-287
-1% -$54.6K 0.5% 84
2017
Q2
$5.61M Sell
29,813
-473
-2% -$85K 0.52% 78
2017
Q1
$5.01M Buy
30,286
+187
+0.6% +$29.7K 0.48% 87
2016
Q4
$4.33M Buy
30,099
+73
+0.2% +$9.78K 0.43% 103
2016
Q3
$3.76M Buy
30,026
+467
+2% +$60.3K 0.4% 105
2016
Q2
$3.88M Buy
29,559
+422
+1% +$57.7K 0.45% 96
2016
Q1
$4.05M Sell
29,137
-976
-3% -$130K 0.49% 89
2015
Q4
$4.2M Buy
30,113
+3,829
+15% +$527K 0.51% 86
2015
Q3
$3.68M Buy
26,284
+646
+3% +$97.1K 0.5% 79
2015
Q2
$4.21M Buy
25,638
+200
+0.8% +$32K 0.53% 74
2015
Q1
$3.93M Sell
25,438
-2,035
-7% -$290K 0.49% 85
2014
Q4
$3.45M Sell
27,473
-512
-2% -$63.3K 0.44% 99
2014
Q3
$3.35M Buy
27,985
+148
+0.5% +$17K 0.47% 94
2014
Q2
$3M Buy
27,837
+23
+0.1% +$2.37K 0.4% 110
2014
Q1
$2.77M Sell
27,814
-295
-1% -$26.7K 0.38% 115
2013
Q4
$2.6M Sell
28,109
-498
-2% -$44.3K 0.35% 122
2013
Q3
$2.39M Sell
28,607
-450
-2% -$38.6K 0.37% 121
2013
Q2
$2.38M Buy
+29,057
New +$2.17M 0.42% 114

Other funds holding ELV

Punch & Associates Investment Management's ELV Position: Q2 2026 in Review

Punch & Associates Investment Management reduced its Elevance Health (ELV) stake by 0.03% in Q2 2026, selling an estimated $2.23K and leaving 23,223 shares worth $8.98M. The position accounts for 0.44% of the portfolio, ranked #81.

Punch & Associates Investment Management first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $14.1M in Q1 2022. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Punch & Associates Investment Management held 23,223 shares of Elevance Health worth $8.98M as of Q2 2026.
  • Punch & Associates Investment Management sold 6 Elevance Health shares in Q2 2026, an estimated $2.23K.
  • Elevance Health made up 0.44% of Punch & Associates Investment Management's portfolio in Q2 2026, its #81 holding.
  • Punch & Associates Investment Management first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
  • Punch & Associates Investment Management's Elevance Health position peaked at $14.1M in Q1 2022.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Punch & Associates Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.